Treatment of reduced bone mineral density in athletic amenorrhea: A pilot study

被引:36
作者
Gibson, JH
Mitchell, A
Reeve, J
Harries, MG
机构
[1] Northwick Pk Hosp, British Olymp Med Ctr, Harrow HA1 3UJ, Middx, England
[2] Northwick Pk Hosp, MRC, Clin Res Ctr, Harrow HA1 3UJ, Middx, England
关键词
athlete; calcium; hormone replacement therapy; menstruation; osteoporosis;
D O I
10.1007/s001980050228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is considerable concern about the adverse effects on the skeleton of loss of menstrual function as a result of athletic activity, as well as uncertainty as to how it should be managed clinically. In a pilot intervention study 34 elite middle and long-distance runners, aged 18-35 years, with menstrual irregularity due to their athletic activity were randomized to three groups: (A) to receive hormone replacement therapy (HRT) and 1000 mg calcium per day (n = 10), (B) to receive 1000 mg calcium per day (n = 14), (C) a control group who received no treatment (n = 10). Bone mineral density (BMD) was measured in the left hip and lumbar spine (L2-4) using dual-energy X-ray absorptiometry. Results were first analyzed according to whether menstruation returned, either naturally or secondary to HRT (EU), and compared with those from subjects who remained amenorrheic (AM). During the first year BMD increased in the EU,group in Ward's triangle (3.8%) and the lumbar spine (4.1%; both P<0.05). BMD fell in the AM group in all regions and the between-group differences were 5.6% (p<0.02) in Ward's triangle, 5.8% (p<0.02) in L2-4 and 3.9% in the trochanter (p<0.05). An 'intention to treat' analysis was then performed. It was found that the mean relative improvement at I year in spinal BMD was only 1.5%, due to return of menses in some of the controls and withdrawals from treatment in the treatment group. In consequence, a trial designed to show, with 80% power and 5% si,significance, a measurable benefit in lumbar spine BMD resulting from allocation to HRT treatment would require about 1150 athletes with amenorrhea or oligomenorrhea. These numbers could be reduced substantially to 380 subjects by confining the trial to completely amenorrheic athletes, who in this study were less likely to regain menses. For these and other logistical reasons, an HRT trial in amenorrheic athletes could only be successfully organized through international collaboration. This study illustrates the major effects of treatment withdrawals and instability of menstrual status on the design of longitudinal studies on the bony effects of menstrual dysfunction prior to menopause.
引用
收藏
页码:284 / 289
页数:6
相关论文
共 17 条
[1]  
Armitage P, 1987, Statistical methods in medical research, V2nd
[2]  
BAER JT, 1992, J SPORT MED PHYS FIT, V32, P51
[3]  
CUMMING RG, 1990, CALCIFIED TISSUE INT, V47, P194
[4]   SUITABILITY OF CYPROTERONE-ACETATE IN THE TREATMENT OF OSTEOPOROSIS ASSOCIATED WITH ATHLETIC AMENORRHEA [J].
DE CREE, C ;
LEWIN, R ;
OSTYN, M .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1988, 9 (03) :187-192
[5]   DUAL X-RAY ABSORPTIOMETRY - CROSS-CALIBRATION AND NORMATIVE REFERENCE RANGES FOR THE SPINE - RESULTS OF A EUROPEAN-COMMUNITY CONCERTED ACTION [J].
DEQUEKER, J ;
PEARSON, J ;
REEVE, J ;
HENLEY, M ;
BRIGHT, J ;
FELSENBERG, D ;
KALENDER, W ;
LAVALJEANTET, AM ;
RUEGSEGGER, P ;
ADAMS, J ;
CURIEL, MD ;
FISCHER, M ;
GALAN, F ;
GEUSENS, P ;
HYLDSTRUP, L ;
JAEGER, P ;
KOTZKI, P ;
KROGER, H ;
LIPS, P ;
MITCHELL, A ;
LOUIS, O ;
CANO, RP ;
POLS, H ;
REID, DM ;
RIBOT, C ;
SCHNEIDER, P ;
LUNT, M .
BONE, 1995, 17 (03) :247-254
[6]   BONE-MINERAL DENSITY AFTER RESUMPTION OF MENSES IN AMENORRHEIC ATHLETES [J].
DRINKWATER, BL ;
NILSON, K ;
OTT, S ;
CHESNUT, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (03) :380-382
[7]   MENSTRUAL HISTORY AS A DETERMINANT OF CURRENT BONE-DENSITY IN YOUNG ATHLETES [J].
DRINKWATER, BL ;
BRUEMNER, B ;
CHESTNUT, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (04) :545-548
[8]   Irreversible bone loss in former amenorrheic athletes [J].
Keen, AD ;
Drinkwater, BL .
OSTEOPOROSIS INTERNATIONAL, 1997, 7 (04) :311-315
[9]  
LINDBERG JS, 1987, WESTERN J MED, V146, P39
[10]   MENSTRUAL FUNCTION AND BONE MASS IN ELITE WOMEN DISTANCE RUNNERS - ENDOCRINE AND METABOLIC FEATURES [J].
MARCUS, R ;
CANN, C ;
MADVIG, P ;
MINKOFF, J ;
GODDARD, M ;
BAYER, M ;
MARTIN, M ;
GAUDIANI, L ;
HASKELL, W ;
GENANT, H .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (02) :158-163